Johnson & Johnson has moved a step closer to filing a potential first-in-class therapy for psoriasis after the drug hit the mark in a phase 3 trial. Once-daily oral IL-23 inhibitor icotrokinra ...

Merck KGaA is shaping up to take on Daiichi Sankyo and Ono Pharma in the market for tenosynovial giant cell tumour (TGCT) therapies after its drug candidate pimicotinib cleared a phase 3 trial.

Description is available under license CC-BY-SA IGO 3.0 Le site de Bellinzone est composé d'un ensemble ... medieval military architecture comprising several castles, linked by a wall that once closed ...

It landed on the inside wall upside-down, shearing the car apart ... which at the time was the closest finish in Indy 500 history. No. 3: Dan Wheldon wins when J.R. Hildebrand crashes on final ...